Explore Our Impact
In the last 10 years we have:
Made revolutionary discoveries, based on the convergence of chemistry, physics, engineering and life sciences, for detection and treatment of cancer, infertility, common and rare neurodegenerative diseases, and imaging and manipulation of cell behavior.
Invested in new translational capabilities that are advancing 6 potential new drugs to clinical testing and 6 through preclinical development.
Incubated 23 new companies that have received more than $1.5B in external investment and are bringing CLP innovations to society.
Acquired more than 50 new instruments and created new services to accelerate transdisciplinary research.
Developed new 21st century curricula and activities to support development of next gen scientists working across disciplinary boundaries to address the big questions in biomedical research.
Raised more than $50M in new external funding to support these efforts.
Imagine what is possible in the next 10 years with additional funding and resources.
Basic Science Discoveries Translated into Healthcare
Professor Richard Silverman (Chemistry and Molecular Biology) is not content to rest on his laurels following his extraordinary discovery of pregabalin (Lyrica®). Instead, he has used the translational resources of the Chemistry of Life Processes Institute to develop...
Nearly 40 million Americans are at risk for vision loss or blindness due to diabetes and age-related macular degeneration. Often, these diseases are diagnosed and treated much too late, after irreversible vision loss has started to occur. Hao F. Zhang (Biomedical...
Thomas O’Halloran (Chemistry and Molecular Biosciences), founding director of the Chemistry of Life Processes Institute, is responsible for the discovery of bis-choline tetra-thiomolybdate, a copper-protein binding agent that safely scavenges excess copper from the...
Luis Schachner, a CLP Predoctoral Trainee and
Howard Hughes Medical Institute Gilliam Fellow,
spearheaded the development of new technology that
measures protein and their complexes with high fidelity
for metal binding and their chemical modifications.